Emerging Technologies: Nanorobotics and its future

Nanorobotics is one aspect of the growing field of nanotechnology

• Small molecular sized nanorobots called Nanobots are programmed to carry out specific functions with their unique properties in various ways
• Measure to a scale of 50-100 nm
• Immense amount of research and development is done in the field of nanotechnology with respect to biomedicine, environment etc.

Applications of Nanobots in the Biomedical Industry

Cancer Diagnosis

A novel approach to early cancer diagnosis could be achieved through nanotechnology, which offers highly sensitive and specific results. Nanobots have been developed to detect cancer biomarkers precisely at low concentration levels, making early detection more effective and overcoming current methods’ limitations.

Adding nanoparticles to biosensors has proven to enhance their effectiveness by making accuracy and delivery efficient.

Drug Delivery

Studies have shown that nanobots may be used to deliver drugs in the future. According to the current results, nanobots may soon be used in humans to deliver drugs more effectively and accurately. Results showed excellent self-propulsive properties and high cargo loading capacities. By making delivery more efficient, current therapeutics may also have fewer harmful side effects.

Locomotion of nanobots are being studied. Multiple technologies such as PET (Positron Emission Tomography), optical energization and propagation has proven nanobots to be accurately transported to the targeted area for effective drug delivery through various media such as human lipids which is non-Newtonian fluid.

Nanomedicine and other applications of Nanobots will be leading the global market towards 2030

• Researchers have shown that investment in this area is expected to surpass $288 Billion by 2030
• A recent market research suggests the nanobots market is expected to grow at a compound annual growth rate (CAGR) of more than 25%
• As a result, that market will be dominated by nanobots used in biomedical and other applications, with an expected rise of 35 percent of the market during that period.
• We believe this technology will go through the right checks and balances in terms of its legal and ethical use as well as efficacy versus collateral issues (side effects).